Welcome to SurgaColl™

SurgaColl™ Technologies Ltd. has developed a range of exciting regenerative technologies based on almost a decade of world class tissue engineering research carried out in the Royal College of Surgeons in Ireland (RCSI). The company's innovative product portfolio is based on a suite of common-platform technologies that offer regenerative solutions in the field of bone and cartilage/osteochondral tissue regeneration.

SurgaColl™ Technologies' products support the body's own natural healing processes, using highly biocompatible, bioactive, and naturally-derived materials to promote faster tissue regeneration without sacrificing quality of healed tissue. SurgaColl™'s technologies are a safe and natural solution to the active patient's demand for rapid return to a healthy and active lifestyle.

News

May 2016: ChondroColl repair of osteochondritis dissecans lesions in an equine athlete.

MORE

May 2016: ChondroColl in the News

MORE

November 2015: SurgaColl competing in IMDA Emerging Medtech Competition

MORE

October 2015: RCSI Study using HydroxyColl as a carrier for osteostatin highlighted in ECM News

MORE

August 2015: SurgaColl announces 2 new hires at DCU Invent

MORE

July 2015: Annagh Haven Horse places 1st again!

MORE

June 2015: Exciting 5 month data from new Equine Clinical Case Study

MORE

May 2015: 2 key SurgaColl-related publications highlighted for merit by Acta Biomaterialia

MORE

April 2015: SurgaColl CEO, Dr. John Gleeson, featured in RCSI Surgical Scope Article

MORE

February 2015: SurgaColl first Equine Clinical Case study published in JTERM

MORE

February 2015: ‘Pioneering’ bone repair technology puts racehorse back on the track - Horse & Hound

MORE

February 2015: Prof. Arthur Tanner joins SurgaColl Board

MORE

February 2015: Dr. Aoife Gallagher joins SurgaColl Board

MORE

February 2015: Prof. O'Brien funding award as part of ERC Proof of Concept grant

MORE

January 2015: AMBER Launch in Dublin generates significant International interest in HydroxyColl Veterinary case study

MORE

January 2015: HydroxyColl Veterinary Case Study garners International Interest

MORE

January 2015: SurgaColl hire new QA/RA Manager

MORE

January 2015: SurgaColl announce move to new Headquarters in DCU Invent Centre

MORE

December 2014: 2014 News Archive

MORE

December 2013: 2013 News Archive

MORE

December 2012: 2012 News Archive

MORE

December 2011: 2011 News Archive

MORE

December 2010: 2010 News Archive

MORE

Bone Repair

hydroxycoll

HydroxyColl™


HydroxyColl™ is a novel bone graft substitute, which combines bone's two main constituents, collagen and hydroxyapatite, in a bioactive scaffold for the repair of bone tissue defects.

find out more



Cartilage Repair

chondrocoll

ChondroColl™


ChondroColl™ is a biomimetic, bioactive layered scaffold for use in the regeneration and repair of osteochondral defects

find out more